First Trust Nasdaq Pharmaceuticals ETF
FTXH
FTXH
21 hedge funds and large institutions have $5.78M invested in First Trust Nasdaq Pharmaceuticals ETF in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Holders
21
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$375K | |
| 2 | +$129K | |
| 3 | +$115K | |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
+$64.3K |
| 5 |
AIP
Ameritas Investment Partners
Lincoln,
Nebraska
|
+$44K |
Top Sellers
| 1 | -$820K | |
| 2 | -$616K | |
| 3 | -$359K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$185K |
| 5 |
NS
NBC Securities
Birmingham,
Alabama
|
-$163K |